Go Back   SEQanswers > Events / Conferences

Similar Threads
Thread Thread Starter Forum Replies Last Post
Join Us for 2 Upcoming Epigenetics eSeminars loretta.manning Events / Conferences 0 01-08-2013 02:00 PM
Join Us for 2 Upcoming Epigenetics eSeminars loretta.manning Epigenetics 0 01-08-2013 11:14 AM
New to NGS Coltom Introductions 0 12-20-2012 08:06 AM
Looking for a few NGS-ers willing to share a bad experience about NGS data analysis CHoyt Bioinformatics 8 12-10-2011 12:06 AM
Strand SI introduces Avadis NGS. NGS analysis for the rest of us! Strand SI Vendor Forum 0 02-14-2011 11:19 AM

Thread Tools
Old 11-22-2013, 09:22 AM   #1
Location: SF Bay area

Join Date: Mar 2012
Posts: 20
Default eSeminar: Next generation sequencing disease research panels

DEC 18 - NATURE Webcast: Pioneering advances in the next generation sequencing clinical research workflow

Breaking barriers with next generation sequencing disease research panels


This webcast will look at how implementing HaloPlex next generation sequencing target enrichment and SureCall analysis software enables fast, simple and efficient analysis of genomic regions of interest in a large number of samples.

In the first presentation, Dr. Ohgami will reveal how the technique has been used in hematolymphoid neoplasms/cancers whose diagnosis and prognosis are increasingly reliant on an understanding of their genetic profile. Testing for specific DNA mutations in certain blood cancers such as myeloid neoplasms has become routine in clinical practice. However, given the large numbers of significant genetic mutations increasingly identified in these diseases, it is also clear that a high-throughput yet tailored approach is required in order to efficiently process and utilize this important additional genetic information. Dr. Ohgami will discuss how he and his laboratory developed a targeted next-generation sequencing approach consisting of a diverse and specific panel of genes tailored towards myeloid neoplasms, as well as its practical development and implementation. Finally, he will describe how the implementation and use of this panel for clinical research will lead to a better understanding of hematolymphoid cancers.

Dr. Baskin will then discuss how she is currently in the process of introducing the HaloPlex targeted enrichment system to research many inherited diseases which are caused by mutations in multiple genes. Previously in order to be able to offer a complete testing panel for certain disease indications, up to 30 candidate genes needed to be sequenced. Currently the method of choice for targeted re-sequencing has been PCR amplification of the genes followed by Sanger sequencing. This procedure is labor intensive, expensive and time consuming, thus it is not economically feasible when many genes need to be analyzed. Dr. Baskin will show how she has set up comprehensive research panels for connective tissue disorders, Noonan spectrum disorders and cardiac disease using HaloPlex sequence capture, and how these panels can be used for high-throughput identification of mutations.


Last edited by loretta.manning; 11-22-2013 at 09:38 AM.
loretta.manning is offline   Reply With Quote

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

All times are GMT -8. The time now is 06:44 PM.

Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2021, vBulletin Solutions, Inc.
Single Sign On provided by vBSSO